Stockreport

Results of Phase I trial shed positive light on UNI-494 for acute kidney injury [Yahoo! Finance]

Unicycive Therapeutics, Inc.  (UNCY) 
PDF Unicycive Therapeutics recently announced positive results from its Phase I trial of UNI-494, [a patented pro-drug of nicorandil which is currently in development for t [Read more]